The Art and Science of Managing Melanoma and Non-Melanoma Skin Cancers

LIVE
The Art and Science of Managing Melanoma and Non-Melanoma Skin Cancers Banner

Add to Calendar The Art and Science of Managing Melanoma and Non-Melanoma Skin Cancers 5/2/2025 12:00:00 PM 5/3/2025 4:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/Art&Science2025 Description: This conference will utilize presentations and case-based panel discussions to illustrate optimal contemporary approaches used to manage patients with melanoma and non-melanoma skin cancers. It will provide learners with practical and useful examples of how to best manage and treat patients with these diseases. Marriott Medical Center Hotel Houston false MM/DD/YYYY


Date & Location
Friday, May 2, 2025, 12:00 PM - Saturday, May 3, 2025, 4:00 PM, Marriott Medical Center Hotel Houston, Houston, TX

Target Audience
Specialties - Complex General Surgical Oncology, Dermatology, Medical Oncology, Pathology
Professions - Physician (MD or DO)

Credits
AMA PRA Category 1 Credits™ (10.75 hours), ABS CC (10.75 hours), Non-Physician Attendance (10.75 hours)

Overview
This conference will utilize presentations and case-based panel discussions to illustrate optimal contemporary approaches used to manage patients with melanoma and non-melanoma skin cancers. It will provide learners with practical and useful examples of how to best manage and treat patients with these diseases.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize emerging data about the potential indications, safety, and efficacy of adjuvant therapy for patients with high-risk clinically localized (stage IIB/C) melanoma and stage III melanoma.
  2. Describe the rationale for neoadjuvant therapy for patients with stage III melanoma and the prognostic significance of the pathological response to treatment.
  3. Summarize treatment options for patients with stage IV melanoma, including in treatment- naïve patients and in patients that previously progressed on anti-PD-1-based immunotherapy.
  4. Recall the available data about the appropriate sequencing of immunotherapy and targeted therapy in treatment-naïve stage IV metastatic melanoma patients with a BRAF V600 mutation.
  5. Describe the differences in the presentation and diagnosis of the various nonmelanoma cutaneous cancers (BCC, SCC, Merkel Cell Carcinomas).
  6. Examine the indications for immunotherapy in nonmelanoma skin cancers, and the subtleties in response patterns and outcomes.

Registration

The Art and Science of Managing Melanoma and Non-Melanoma Skin Cancers will begin on Friday, May 2, 2025, with Opening Remarks at 1:00 PM and will adjourn on Saturday, May 3, 2025 at 4:00 PM. This conference will be held at the Marriott Medical Center Hotel Houston, 6580 Fannin Street, Houston TX 77030.

CONFERENCE REGISTRATION FEES

MD Anderson Physicians – Fee Exempt

MD Anderson RN’s/PA’s/NP’s/Trainees/Non-Clinical – Fee Exempt

MDA Cancer Network Partner (Verification Required) – Fee Exempt

 

Non-MDA Physicians

Postmarked before May 2, 2025

$100.00

Postmarked after May 2, 2025

$150.00

Non-MDA RN’s/PA’s/NP’s/Trainees/Non-Clinical

Postmarked before May 2, 2025

$75.00

Postmarked after April 14, 2025

$100.00

 We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check (payable to The University of Texas MD Anderson Cancer Center through U.S. banks only)

Mail checks to:

     Continuing Professional Education – Unit 1781
     The University of Texas MD Anderson Cancer Center
     P.O. Box 301407
     Houston, TX 77230-1407

Telephone registrations will not be accepted.

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.  Once your payment has been made, a receipt can be found in the MyCE tab of your PEP@MD Anderson account. 

Refund/Cancellation Policy
The registration fee, minus a $35.00 administration-handling fee, is refundable if a written request is received on or before Friday, April 11, 2025.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the Department of Continuing Professional Education, is limited to the registration fee. CPE will refund the full registration fee. 
 
The Department of Continuing Professional Education, reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

Special Assistance

For additional information contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]. If you have any ADA accommodation needs or need assistance.

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. The survey link will be provided during the review course.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation: 
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 10.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


American Board of Surgery CC Credit:
Successful completion of this CME activity, enables the learner to earn credit toward the CME of the American Board of Surgery's Continous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for purpose of granting ABS credit.


Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.